PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

National Health Investors, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from National Health Investors, Inc.'s yearly results (2022–2025), compared with Real Estate companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 94% of Real Estate companies in United States.

Where $100 of sales goes

$49Operating costs$14Interest$38Net profit$45Paid as dividends

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

$151

Over the last 3 years, every $100 of reported profit came with $151 of operating cash.

Lower than 68% of Real Estate companies in United States.

Self-Funding Ratio

—

Data incomplete

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

3/3 · 3/3

Sales and profit both grew in each of the last 3 years.

Steadier than 94% of Real Estate companies in United States.

Growth Efficiency Ratio

$78

Sales grew 35% in 3 years; of every extra $100 of sales, $78 became extra profit.

Higher than 82% of Real Estate companies in United States.

Asset Productivity Ratio

+35% / +12%

In 3 years sales changed by +35% while total assets changed by +12%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

1.2×

Debt due within a year is covered 1.2 times by its yearly operating cash.

Lower than 53% of Real Estate companies in United States.

Cash Cushion Ratio

−35%

Debt, after subtracting cash, equals 35% of its market value (net debt).

Higher than 77% of Real Estate companies in United States.

Tangible Assets Ratio

—

Data incomplete

Tangible Net Worth Ratio

—

Data incomplete

Shareholders

Shareholder Slice Ratio

+11%

Share count rose 11% in 3 years, so each share's slice of the company became smaller. Dividends paid equalled 116% of profit over the same period.

Bigger rise in share count than 66% of Real Estate companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

National Health Investors, Inc. owes $0.46 for every $1 it owns. Net profit rose 3% in the year to Dec 2025, and grew 29% a year on average over 3 years.

Compared with Real Estate companies in United States · latest annual results Dec 2025.

P/E ratio

19.4

Investors pay $19.4 for every $1 of National Health Investors, Inc.'s yearly profit, lower than 61% of Real Estate companies in United States.

P/B ratio

2.09

The share price is 2.09 times National Health Investors, Inc.'s book value per share, higher than 75% of Real Estate companies in United States.

Market cap

$3.3 B

The total market value of all of National Health Investors, Inc.'s shares at today's price (share price × number of shares), larger than 63% of Real Estate companies in United States. PosiCap size class: Meso Cap.

Net worth (book value)

$1.6 B

What National Health Investors, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$32.00

Net worth divided by the number of shares. The share price of $66.96 is 2.1 times this, which is the P/B above.

Return on equity (ROE)

10.7%

National Health Investors, Inc. earned 10.7% on its shareholders' money over the last year, higher than 79% of Real Estate companies in United States.

Owes vs Owns

0.46×

National Health Investors, Inc. owes $0.46 for every $1 it owns (low), lower than 69% of Real Estate companies in United States.

Dividend yield

5.79%

National Health Investors, Inc. pays 5.79% of its share price as dividends a year, higher than 53% of dividend-paying Real Estate companies in United States.

Revenue growth

+12%

Revenue rose 12% in the year to Dec 2025, and grew 11% a year on average over 3 years.

Profit growth

+3%

Net profit rose 3% in the year to Dec 2025, and grew 29% a year on average over 3 years.

Profit margin

37.9%

National Health Investors, Inc. keeps $38 of every $100 of revenue as net profit.

Cash quality

1.7×

Cash from National Health Investors, Inc.'s business was 1.7× its reported profit in the year to Dec 2025 — its profit turned into cash.

Interest cover

3.5×

National Health Investors, Inc.'s operating profit covered its interest costs 3.5 times in the year to Dec 2025.

Cash vs debt

Net debt

National Health Investors, Inc. had $1.1 B more debt than cash (net debt) at Dec 2025.

Questions

What is National Health Investors, Inc.'s P/E ratio?

Investors pay $19.4 for every $1 of National Health Investors, Inc.'s yearly profit, lower than 61% of Real Estate companies in United States.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For National Health Investors, Inc.: $3.3 B ÷ $1.6 B (30 Jun 2026) = 2.1.

What is National Health Investors, Inc.'s return on equity?

National Health Investors, Inc. earned 10.7% on its shareholders' money over the last year, higher than 79% of Real Estate companies in United States.

How much does National Health Investors, Inc. owe compared with what it owns?

National Health Investors, Inc. owes $0.46 for every $1 it owns (low), lower than 69% of Real Estate companies in United States.

Does National Health Investors, Inc. pay a dividend?

Yes. National Health Investors, Inc. pays 5.79% of its share price as dividends a year, higher than 53% of dividend-paying Real Estate companies in United States.

Is National Health Investors, Inc.'s revenue growing?

Revenue rose 12% in the year to Dec 2025, and grew 11% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.